Sarcomatoid hepatocellular carcinoma: From clinical features to cancer genome.

Zhang, Cheng; Feng, Shi; Tu, Zhenhua; Sun, Jingqi; Rui, Tao; Zhang, Xueyou; Huang, Haitao; Ling, Qi; Zheng, Shusen

Zhang, Cheng; Feng, Shi; Tu, Zhenhua; Sun, Jingqi; Rui, Tao; Zhang, Xueyou; Huang, Haitao; Ling, Qi; Zheng, Shusen.

Afiliación

Zhang C; Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Feng S; Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Tu Z; Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun J; Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Rui T; Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhang X; Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huang H; Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ling Q; Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zheng S; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China.

Cancer Med ; 10(18): 6227-6238, 2021 09.

Article en En | MEDLINE | ID: mdl-34331411

Asunto(s)

Carcinoma Hepatocelular/genética; Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética; Neoplasias Hepáticas/genética; Hígado/patología; Recurrencia Local de Neoplasia/epidemiología; Anciano; Aminopiridinas/uso terapéutico; Bencimidazoles/uso terapéutico; Carcinoma Hepatocelular/diagnóstico; Carcinoma Hepatocelular/mortalidad; Carcinoma Hepatocelular/terapia; Quimioterapia Adyuvante; ADN Helicasas/genética; Supervivencia sin Enfermedad; Femenino; Estudios de Seguimiento; Hepatectomía; Humanos; Hígado/cirugía; Neoplasias Hepáticas/diagnóstico; Neoplasias Hepáticas/mortalidad; Neoplasias Hepáticas/terapia; Quinasa 1 de Quinasa de Quinasa MAP/genética; Masculino; Persona de Mediana Edad; Tasa de Mutación; Recurrencia Local de Neoplasia/genética; Recurrencia Local de Neoplasia/patología; Recurrencia Local de Neoplasia/prevención & control; Pronóstico; Receptor EphA5/genética; Factores de Riesgo; Carga Tumoral

Palabras clave

genome; sarcomatoid hepatocellular carcinoma; survival; therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Inhibidor p16 de la Quinasa Dependiente de Ciclina / Hígado / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google